Product image of Mannitol Viaflo Baxter (Mannitol) supplied by GNH India

Mannitol Viaflo Baxter

Active Ingredient:
Mannitol
Origin:
EU

Mannitol Viaflo Baxter (Mannitol)

Mannitol, the active ingredient in Mannitol Viaflo Baxter, is an osmotic diuretic presented as an intravenous solution for intravenous use. It reduces intracranial and intraocular pressure and promotes diuresis in acute renal failure, primarily in hospital patients.
GNH India supplies Mannitol Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Baxter Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mannitol acts as an osmotic diuretic and is employed in several acute medical conditions.

  • Intracranial hypertension: lowers intracranial pressure in patients with cerebral edema or trauma.
  • Elevated intraocular pressure: reduces pressure in acute glaucoma or ocular surgery.
  • Acute renal failure: promotes diuresis to facilitate fluid removal and improve renal output.
  • Toxic renal excretion: enhances renal clearance of nephrotoxic substances such as certain contrast agents.

How It Works

  • Mannitol increases extracellular osmolarity by remaining largely confined to the vascular compartment. This osmotic gradient draws water from intracellular spaces into the bloodstream, expanding plasma volume and inducing diuresis. The resulting reduction in tissue water content lowers intracranial and intraocular pressure, while the increased urine flow assists in the elimination of renal toxins.

Side Effects

Mannitol may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Headache: mild to moderate discomfort often related to rapid osmotic shifts.
  • Nausea or vomiting: gastrointestinal upset following infusion.
  • Electrolyte imbalance: transient changes in serum sodium or potassium.
  • Hypotension: drop in blood pressure due to plasma volume expansion.

Serious or Rare Side Effects

  • Acute renal failure worsening: especially in patients with pre‑existing kidney disease.
  • Pulmonary edema: fluid overload leading to respiratory compromise.
  • Severe electrolyte disturbances: marked hypernatremia or hypokalemia.
  • Anaphylactoid reaction: rare hypersensitivity presenting with rash, bronchospasm, or shock.

Precautions & Warnings

Mannitol requires careful clinical monitoring to minimise risks.

  • Assess renal function: evaluate baseline creatinine and urine output before use.
  • Monitor electrolytes: check serum sodium, potassium, and osmolality during therapy.
  • Avoid rapid infusion: administer over the recommended time to reduce cardiovascular stress.
  • Use cautiously in heart failure: risk of volume overload and pulmonary edema.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Mannitol can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid)

  • Loop diuretics: may cause severe electrolyte depletion.
  • ACE inhibitors or ARBs: increased risk of hypotension and renal impairment.
  • Nephrotoxic agents (e.g., aminoglycosides): heightened potential for kidney injury.

Moderate Interactions (Monitor Closely)

  • Insulin: osmotic shifts can potentiate hypoglycaemia.
  • Antiepileptic drugs: altered plasma concentrations may affect seizure control.
  • Iodinated contrast media: combined renal stress may exacerbate nephropathy.

Frequently Asked Questions

Mannitol Viaflo Baxter is an intravenous osmotic diuretic used to lower elevated intracranial and intraocular pressure, to promote diuresis in acute renal failure, and to enhance renal excretion of certain toxins. It is administered in hospital settings under physician supervision.

Mannitol works by increasing the osmolarity of the extracellular fluid. This draws water from cells into the vascular space, expanding plasma volume, reducing tissue swelling, and stimulating urine production, which helps lower pressure in the brain and eye and clears renal toxins.

The dose of Mannitol Viaflo Baxter is individualized by the prescribing clinician based on the patient’s condition, weight, renal function, and response. Healthcare professionals determine the appropriate concentration, infusion rate, and total volume for each case.

Mannitol’s safety in pregnancy and lactation has not been definitively established. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Mannitol is a widely used osmotic diuretic with rapid onset and predictable renal clearance. Compared with alternatives such as hypertonic saline, mannitol provides both diuretic and volume‑expanding effects, but may carry a higher risk of electrolyte disturbances and requires careful monitoring.

Mannitol Viaflo Baxter should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and allow the product to reach room temperature if required for infusion.

Mannitol Viaflo Baxter is given intravenously. The infusion rate and total dose are determined by the treating physician, who may adjust the speed based on the patient’s hemodynamic status and target therapeutic effect. Administration is typically performed in a monitored clinical environment.

Serious risks include acute renal failure worsening, severe electrolyte imbalances (especially hypernatremia), pulmonary edema from fluid overload, and rare anaphylactoid reactions. Prompt recognition of symptoms and regular laboratory monitoring are essential to mitigate these hazards.

Mannitol is contraindicated in patients with known hypersensitivity to mannitol, severe dehydration, active intracranial bleeding, uncontrolled heart failure, and those with severe renal impairment where diuresis cannot be achieved safely.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.